X4 Pharmaceuticals (XFOR) Net Income Growth (3y) (2020 - 2025)
X4 Pharmaceuticals (XFOR) Net Income Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 38.43% |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 13.80% |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | -3.84% |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 87.54% |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 47.10% |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | - |
| 10 | X4 Pharmaceuticals | 158.18 Mn | -58.87 Mn | 2.20 Mn | 6.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.32% |
| Sep 30, 2025 | -11.37% |
| Jun 30, 2025 | -6.66% |
| Mar 31, 2025 | 26.26% |
| Dec 31, 2024 | -9.65% |
| Sep 30, 2024 | -22.07% |
| Jun 30, 2024 | 87.82% |
| Mar 31, 2024 | -40.47% |
| Dec 31, 2023 | -1.31% |
| Sep 30, 2023 | 49.07% |
| Jun 30, 2023 | -54.37% |
| Mar 31, 2023 | -29.20% |
| Dec 31, 2022 | -39.00% |
| Sep 30, 2022 | -6.81% |
| Jun 30, 2022 | -16.59% |
| Mar 31, 2022 | -26.41% |
| Dec 31, 2021 | -54.19% |
| Sep 30, 2021 | -32.66% |
| Jun 30, 2021 | -44.61% |
| Mar 31, 2021 | -44.10% |